金融界1月6日消息,新华制药发布异动公告,公司2025年1月3日、1月6日A股股票连续两个交易日收盘价格涨幅偏离值累计达到20%。针对股票异常波动,公司核查后,前期披露的信息无需更正、补充,未发现近期公共传媒报道的未公开重大信息,经营情况及内外部环境未变。2025年1月2日披露了多则相关公告,2024年12月10日也有披露。公司未发现其他重大信息,控股股东、实际控制人无应披露未披露事项,未买卖股票...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.